The Risk of Breast Cancer in Postmenopausal Women Who Have Used Estrogen Replacement Therapy

JAMA: The Journal of the American Medical Association

Volumn 257, Issue 2, 1987, Pages 209-215

  Wingo, Phyllis A ^a   Layde, Peter M ^a   Lee, Nancy C ^a   Rubin, George ^a   Ory, Howard W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN;

ADULT; ADVERSE DRUG REACTION; BREAST; BREAST CANCER; CARCINOGENESIS; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DRUG THERAPY; ENDOCRINE SYSTEM; EPIDEMIOLOGY; ESTROGEN THERAPY; FEMALE GENITAL SYSTEM; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; THERAPY;

ADULT; BREAST NEOPLASMS; EPIDEMIOLOGIC METHODS; ESTROGENS; FEMALE; HUMANS; INTERVIEWS; MENOPAUSE; MIDDLE AGED; OVARIECTOMY; RISK; UNITED STATES;

EID: 84948010547     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1987.03390020075030     Document Type: Article

References (21)

1. Bush TL, Barrett-Connor E: Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev 1985;7:80-104.
2. Kennedy D, Baum C, Forbes M: Noncontraceptive estrogens and progestins: Use patterns over time. Obstet Gynecol 1985;65:441-446.
3. Silverberg E, Lubera J: Cancer statistics, 1986. CA 1986;36:9-25.
4. Sartwell PE, Arthes FG, Tonascia JA: Exogenous hormones, reproductive history and breast cancer. JNCI 1977;59:1589-1592.
5. Kelsey JL, Fischer DB, Holford TR, et al.: Exogenous estrogens and other factors in the epidemiology of breast cancer. JNCI 1981;67: 327-333.
6. Kaufman DW, Miller DR, Rosenberg L, et al.: Noncontraceptive estrogen use and the risk of breast cancer. JAMA 1984;252:63-67.
7. Jick H, Walker AM, Watkins RN, et al.: Replacement estrogen and breast cancer. Am J Epidemiol 1980;112:586-594.
8. Ross RK, Paganini-Hill A, Gerkins VR: A case-control study of menopausal estrogen therapy and breast cancer. JAMA 1980;243:1635-1639.
9. Hulka B: Effect of exogenous estrogen on postmenopausal women: The epidemiologic evidence. Obstet Gynecol Surv 1980;35:389-399.
10. Hoover R, Glass A, Finkle W, et al.: Conjugated estrogens and breast cancer risk in women. JNCI 1981;67:815-820.
11. Hoover R, Gray L, Cole P, et al.: Menopausal estrogens and breast cancer. N Engl J Med 1976; 295:401-405.
12. Brinton LA, Hoover RN, Szklo M, et al.: Menopausal estrogen use and risk of breast cancer. Cancer 1981;47:2517-2522.
13. Thomas DB: Do hormones cause breast cancer? Cancer 1984;53:595-604.
14. Hulka B, Chambless LE, Deubner DC, et al.: Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 1982;143:638-644.
15. Centers for Disease Control Cancer and Ster- oid Hormone Study: Long-term oral contraceptive use and the risk of breast cancer. JAMA 1983;249: 1591-1595.
16. Waksberg J: Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-46.
17. Schlesselman J: Case-Control Studies. New York, Oxford University Press Inc, 1982.
18. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959;22:719-748.
19. Thomas LB, Ackerman LV, McDivitt RW, et al.: Report of NCI ad hoc pathology working group to review gross and microscopic findings of breast cancer cases in the HIP study. JNCI 1977;59: 497-541.
20. Coulter A, Vessey M, McPherson K: The ability of women to recall their oral contraceptive histories. Contraception 1986;33:127-138.
21. Brinton LA, Williams RR, Hoover RM, et al.: Breast cancer risk factors among screening program participants. JNCI 1979;62:37-44.